Longeveron LLC
Longeveron is a global leader in stem cell therapies, developing regenerative medicine solutions for life-threatening and aging-related conditions. The company's mission is to improve healthspan through innovative cell-based therapeutics, with a focus on diseases such as Hypoplastic Left Heart Syndrome, Alzheimer’s Disease, and Aging Frailty. With a strong research pipeline, clinical trials, and a state-of-the-art GMP manufacturing facility, Longeveron aims to bring safe and effective regenerative treatments to patients worldwide.
Industries
Nr. of Employees
small (1-50)
Products
Allogeneic bone-marrow-derived mesenchymal stromal cell therapeutic candidate
Investigational allogeneic MSC product manufactured via culture expansion, formulated and cryopreserved for clinical use across indications including congenital heart disease (HLHS), neurodegeneration (Alzheimer’s), aging-related frailty, ARDS and metabolic syndrome.
Allogeneic bone-marrow-derived mesenchymal stromal cell therapeutic candidate
Investigational allogeneic MSC product manufactured via culture expansion, formulated and cryopreserved for clinical use across indications including congenital heart disease (HLHS), neurodegeneration (Alzheimer’s), aging-related frailty, ARDS and metabolic syndrome.
Services
CDMO services for cell therapies
Facility-based contract development and manufacturing services for preclinical and clinical cell therapy programs including process development, analytical/QC testing and cGMP clinical manufacturing.
Clinical trial operations and registry sponsorship
Sponsorship and operational management of multi-phase clinical studies and treatment registry programs, including randomized and controlled trial execution and long-term follow-up data collection.
Analytical and QC testing services
On-site laboratory analytical testing and assay support for cell therapy development, including flow cytometry, molecular assays, immunoassays and rapid microbiological testing to support lot release.
CDMO services for cell therapies
Facility-based contract development and manufacturing services for preclinical and clinical cell therapy programs including process development, analytical/QC testing and cGMP clinical manufacturing.
Clinical trial operations and registry sponsorship
Sponsorship and operational management of multi-phase clinical studies and treatment registry programs, including randomized and controlled trial execution and long-term follow-up data collection.
Analytical and QC testing services
On-site laboratory analytical testing and assay support for cell therapy development, including flow cytometry, molecular assays, immunoassays and rapid microbiological testing to support lot release.
Expertise Areas
- cGMP cell therapy manufacturing
- Process development and scale-up for cell therapeutics
- Clinical trial management and registry operations
- Regulatory strategy for biologics and cell therapies
Key Technologies
- Mesenchymal stromal cell culture and expansion
- Cryopreservation and frozen-chain logistics
- Flow cytometry
- PCR / qRT-PCR